These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 18055666

  • 21. [Medication for ADHD and the risk of cardiovascular mortality].
    Langendijk PN, Wilde AA.
    Ned Tijdschr Geneeskd; 2006 Aug 05; 150(31):1713-4. PubMed ID: 16924941
    [Abstract] [Full Text] [Related]

  • 22. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M.
    Pediatrics; 2007 Jan 05; 119(1):154-5. PubMed ID: 17200281
    [No Abstract] [Full Text] [Related]

  • 23. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder.
    Poulton A.
    Curr Opin Pediatr; 2006 Aug 05; 18(4):427-34. PubMed ID: 16914999
    [Abstract] [Full Text] [Related]

  • 24. Association between treatment with central nervous system stimulants and Raynaud's syndrome in children: a retrospective case-control study of rheumatology patients.
    Goldman W, Seltzer R, Reuman P.
    Arthritis Rheum; 2008 Feb 05; 58(2):563-6. PubMed ID: 18240233
    [Abstract] [Full Text] [Related]

  • 25. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system.
    Gau SS, Chang LY, Huang LM, Fan TY, Wu YY, Lin TY.
    Pediatrics; 2008 Aug 05; 122(2):e452-8. PubMed ID: 18606624
    [Abstract] [Full Text] [Related]

  • 26. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J.
    J Clin Psychiatry; 2003 Aug 05; 64 Suppl 11():3-8. PubMed ID: 14529323
    [Abstract] [Full Text] [Related]

  • 27. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May 05; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 28. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR, Whitney J, Gonzalez-Heydrich J.
    Epilepsy Behav; 2008 Feb 05; 12(2):217-33. PubMed ID: 18065271
    [Abstract] [Full Text] [Related]

  • 29. Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study.
    Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, Zito J, Shuster JJ, Olfson M.
    BMJ; 2012 Jul 18; 345():e4627. PubMed ID: 22809800
    [Abstract] [Full Text] [Related]

  • 30. Effect of stimulants on height and weight: a review of the literature.
    Faraone SV, Biederman J, Morley CP, Spencer TJ.
    J Am Acad Child Adolesc Psychiatry; 2008 Sep 18; 47(9):994-1009. PubMed ID: 18580502
    [Abstract] [Full Text] [Related]

  • 31. Cardiac arrest with pulseless electrical activity associated with methylphenidate in an adolescent with a normal baseline echocardiogram.
    Daly MW, Custer G, McLeay PD.
    Pharmacotherapy; 2008 Nov 18; 28(11):1408-12. PubMed ID: 18957001
    [Abstract] [Full Text] [Related]

  • 32. Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.
    Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, Marcus SC.
    J Am Acad Child Adolesc Psychiatry; 2012 Feb 18; 51(2):147-56. PubMed ID: 22265361
    [Abstract] [Full Text] [Related]

  • 33. Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments.
    Stein MA.
    Am J Manag Care; 2004 Jul 18; 10(4 Suppl):S89-98. PubMed ID: 15352535
    [Abstract] [Full Text] [Related]

  • 34. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
    Lawson KA, Johnsrud M, Hodgkins P, Sasané R, Crismon ML.
    Clin Ther; 2012 Apr 18; 34(4):944-956.e4. PubMed ID: 22444786
    [Abstract] [Full Text] [Related]

  • 35. Stimulant medications.
    Greenhill LL, Halperin JM, Abikoff H.
    J Am Acad Child Adolesc Psychiatry; 1999 May 18; 38(5):503-12. PubMed ID: 10230181
    [Abstract] [Full Text] [Related]

  • 36. Growth on stimulant medication; clarifying the confusion: a review.
    Poulton A.
    Arch Dis Child; 2005 Aug 18; 90(8):801-6. PubMed ID: 16040876
    [Abstract] [Full Text] [Related]

  • 37. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
    Marcus SC, Durkin M.
    J Am Acad Child Adolesc Psychiatry; 2011 May 18; 50(5):480-9. PubMed ID: 21515197
    [Abstract] [Full Text] [Related]

  • 38. Childhood stimulant treatment and risk for later substance abuse.
    Fischer M, Barkley RA.
    J Clin Psychiatry; 2003 May 18; 64 Suppl 11():19-23. PubMed ID: 14529326
    [Abstract] [Full Text] [Related]

  • 39. Management of a hyperactive teen and cardiac safety.
    Sowinski H, Karpawich PP.
    Pediatr Clin North Am; 2014 Feb 18; 61(1):81-90. PubMed ID: 24267459
    [Abstract] [Full Text] [Related]

  • 40. Medications for adolescents with attention-deficit/hyperactivity disorder.
    Soileau EJ.
    Adolesc Med State Art Rev; 2008 Aug 18; 19(2):254-67, viii-ix. PubMed ID: 18822831
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.